ArticleFrontiers in immunology2026
N-myc and STAT interactor promotes poly(I:C)-induced pulmonary coagulopathy via STAT3-dependent tissue factor.
Article in Frontiers in immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Viral pneumonia-associated coagulopathy is a major determinant of mortality, yet the upstream molecular drivers initiating the coagulation cascade remain incompletely understood. Methods: We integrated bulk and single-cell transcriptomics to map viral infection signatures. Mechanistic and therapeutic evaluations were performed in a poly(I:C)-induced pneumonia model utilizing candidate gene-knockout mice and STAT3 inhibition (Stattic), with endpoints including lung injury, tissue factor (TF) expression, and microthrombosis. Results: We identified N-myc and STAT interactor (NMI) as a critical damage-associated molecular pattern (DAMP) promoting poly(I:C)-induced pulmonary coagulopathy. Transcriptomic analyses across human and murine viral pneumonia datasets revealed robust NMI upregulation, which strongly correlated with coagulation markers. Mechanistically, extracellular NMI activates alveolar epithelial STAT3 signaling, directly upregulating TF to initiate the extrinsic coagulation cascade. Conclusion: Our findings elucidate the NMI-STAT3-TF axis as a key contributor to pulmonary coagulopathy. Targeting this axis may offer a potential preclinical therapeutic strategy for managing thrombotic complications in virus-induced lung inflammation.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.